dto UM | M4 ) LR COUNTY, ) MAY 12, 18 rs wi NUMBER 9.
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial - eClinicalMedicine